By Stacy Cappadona, MS, RD, CSSD, CSCS, TSAC-F, OmegaQuant Science Writer & Reviewer 

Stacy Cappadona is OmegaQuant’s science writer and reviewer. She is a registered dietitian and board-certified specialist in sports dietetics. Stacy has spent most of her career supporting the health and performance of United States military communities, applying evidence-based nutrition strategies to meet the demands of high-stress, high-performance environments. Learn more

 

Key Points:

  • A UK Biobank study of 272,000+ people found that higher blood levels of linoleic acid (LA), an omega-6 fat, were associated with lower body weight, waist circumference, and body fat.
  • The findings challenge claims that omega-6 fats and seed oils are major drivers of obesity.
  • The study used blood biomarkers rather than self-reported food intake, providing a more objective measure of omega-6 status.
  • The results are observational, so they don’t prove cause and effect, but they support including LA-rich foods as part of a healthy diet.

 

For years, omega-6 fatty acids—particularly linoleic acid (LA)—have been criticized for allegedly promoting inflammation and weight gain. But does the science support those claims?

A new study of more than 272,000 UK Biobank participants found just the opposite: individuals with higher blood levels of linoleic acid had lower body weight, smaller waist circumferences, and less body fat (1). Although the findings are observational and don’t prove cause and effect, they add to a growing body of evidence that challenges common misconceptions about omega-6s and highlights the importance of measuring fatty acids—not just estimating dietary intake.

VIDEO: Why You need Higher Doses of Omega-3 than You Think

 

Why Omega-6 Fatty Acids Have Been So Controversial

Obesity has become a global health crisis. According to the World Health Organization, more than 1 billion people are living with obesity, and the prevalence is rising worldwide (2). Given the growing numbers and related concerns, citizens and scientists alike have been searching for the causes and determinants of obesity to address the problem. Interestingly, concerns about obesity rates have led people to look more closely at omega-6 fatty acids, such as LA.

Two primary arguments have driven investigations into omega-6 fats as drivers of obesity. First, ecological trends. Over time, people observed a parallel rise in obesity rates and the dramatic increase in the use and consumption of omega-6 fatty acids, primarily from LA-rich seed oils. A historical narrative developed, suggesting that contemporary hunter-gatherer populations consumed fewer omega-6 fats in their natural diet and that the high levels we consume today go against our natural biology. This idea was supported by researchers noting that LA was one of the most abundant fatty acids in adipose tissue (fat tissue) and that adipose tissue LA levels increased in correlation with increased dietary intake over time (3).

Second, LA is a precursor to the omega-6 fatty acid arachidonic acid (AA). AA, in turn, serves as a substrate for pro-inflammatory eicosanoids (4). This idea further fueled the conjecture that LA intake may lead to chronic inflammation and central obesity (5). These narratives have been amplified by wellness influencers on social media and podcast platforms, cementing this concept among the general population over time.

However, the correlation between increased omega-6 intake and obesity does not imply causation. Many professionals argue that the rise in obesity also correlates with other variables, such as more sedentary lifestyles, greater overall calorie availability, and increased consumption of ultra-processed foods. So, the argument that increased intake of omega-6 fatty acids, like LA, from seed oils has caused increases in obesity remains a heavily debated topic.

Finally, some of the evidence on this topic is mixed, likely due to limitations in study design or unrealistic methodologies. For example, one animal study that found dietary LA promoted weight gain provided a diet comprising 22.5% of energy intake from LA alone (6). These levels far exceed typical human intake. Alternatively, few studies have used objective biomarkers and instead rely on self-reported food intake, which is typically less consistent (7).

Interestingly, more recent evidence appears to directly challenge the narrative that omega-6 fats — especially those in seed oils — are driving obesity.

VIDEO: The Science of ‘Inflammaging’

 

What This UK Biobank Study Found

To address previous limitations, a recent study examined the cross-sectional and longitudinal relationships between circulating LA levels and body weight and adiposity outcomes in the UK Biobank (1). This means that they looked at whether the amount of LA in the blood was related to people’s body weight and body fat, both at one point in time and over time.

Published in the British Journal of Nutrition, the study analyzed data from more than 272,000 UK Biobank participants and is among the largest to date examining the relationship between omega-6 fatty acids and adiposity using objective blood biomarkers. The researchers measured plasma LA, non-LA omega-6s, and total omega-6s. They also assessed waist circumference, body weight, whole-body fat mass, BMI, whole-body fat-free mass, trunk fat mass, and trunk fat percentage.

In the cross-sectional analyses (the relationship at a single time point), the researchers found that plasma LA and total omega-6 polyunsaturated fatty acids were inversely associated with waist circumference, weight, and whole-body fat mass. In contrast, non-LA omega-6 fats were associated with greater waist circumference, weight, and whole-body fat mass. Longitudinal analyses assessing annual change showed largely the same results.

Findings for BMI, whole-body fat-free mass, trunk fat mass, and trunk fat percentage were similar. Cross-sectional associations aligned with primary outcomes; higher levels of LA and total omega-6 were linked to lower BMI, whole-body fat-free mass, trunk fat mass, and trunk fat percentage, whereas non-LA omega-6 showed the opposite pattern. Longitudinal findings showed minor differences: the relationship between LA and whole-body fat-free mass was neutral, and total omega-6 was linked to increased whole-body fat-free mass.

The authors also note that even when considering total omega-6 fats, the overall association is inverse (beneficial for body fat and weight measures) because the association with non-LA omega-6 fats and body fat was relatively weak. Further, they noted that this difference in effects of omega-6 fats warrants further research that treats all omega-6 fats separately rather than as a single homogeneous group, and that the weak positive association of non-LA fats may be minimizing the positive influence of LA in other studies where they are not separated.

VIDEO: The Latest Research on Omega-6 

 

Why Blood Biomarkers Matter More Than Food Questionnaires

One aspect that makes this recent study so unique is that it uses objective biomarkers to assess dietary intake rather than relying on self-reporting. Documenting what individuals consume in nutrition research has long been a major challenge. Commonly used self-reported dietary assessment methods include recall surveys, food diaries, and food frequency questionnaires. But all of these are prone to misreporting, and evidence shows strong and consistent systemic underreporting (7). People may forget foods, misjudge portion sizes, or intentionally omit intake.

Alternatively, measuring nutritional biomarkers, such as circulating omega-6 fatty acids, provides a more objective picture of nutritional status. It not only reflects dietary exposure but also more accurately reflects the absorption of the nutrients in question. Eating food does not necessarily mean that your body absorbs and uses it. Blood tests provide a direct, objective picture of what has entered your system – and yes, they reflect your intake.

VIDEO: Oxidized Fish Oil – Are You Paying for Poison?

 

What These Findings Mean for Seed Oils and Dietary Guidance

Altogether, these findings show that circulating plasma LA levels may play a protective role in body weight regulation—directly challenging the narrative that all seed oils are harmful and that they are primary drivers of obesity rates. Furthermore, evidence indicates they are also heart-healthy (8).

LA is an essential omega-6 polyunsaturated fatty acid. This means that humans cannot synthesize it on their own and must obtain it from the diet. Although “optimal” intake has not been identified, the dietary reference intakes have set an adequate intake (AI) of 12 g/d for women and 17 g/d for men between the ages of 19-50 (9).

These recent findings support dietary guidance that emphasizes including LA-rich foods, such as nuts, seeds, soybeans, corn, and sunflower oils, as part of a balanced diet for health and weight management. Furthermore, these findings highlight the need to study omega-6 fats individually, rather than as a single large group.

VIDEO: What Influencers Get Wrong About Seed Oils

 

The Bottom Line: Focus on the Evidence, Not the Hype

The current body of evidence does not support the idea that LA—or omega-6 fatty acids as a whole—should be blamed for the rise in obesity. Their effects may even be protective against obesity.

In a recent large UK Biobank study, higher circulating LA was consistently associated with lower body weight, waist circumference, and body fat. While these observational findings cannot establish that LA itself is the cause of lower adiposity, they add to the growing body of evidence that challenges the narrative that omega-6 fats and seed oils are inherently harmful and obesogenic, and that they can be included as part of a healthy dietary pattern.

 

References:

  1. Lai HTM, Westra J, De Jong E, Tintle NL, Belury MA, Harris WS. Omega-6 polyunsaturated fatty acids and adiposity in the UK Biobank Cohort: a cross-sectional and longitudinal prospective analysis. Preprint.medRxiv. 2025;2025.09.24.25336554. Published 2025 Sep 27. doi:10.1101/2025.09.24.25336554
  2. World Health Organization. (2025, December 8).Obesity and overweighthttps://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
  3. Guyenet SJ, Carlson SE. Increase in adipose tissue linoleic acid of US adults in the last half century.Adv Nutr. 2015;6(6):660-664. Published 2015 Nov 13. doi:10.3945/an.115.009944
  4. DiNicolantonio JJ, O’Keefe JH. Omega-6 vegetable oils as a driver of coronary heart disease: the oxidized linoleic acid hypothesis.Open Heart. 2018;5(2):e000898. Published 2018 Sep 26. doi:10.1136/openhrt-2018-000898
  5. Innes JK, Calder PC. Omega-6 fatty acids and inflammation.Prostaglandins Leukot Essent Fatty Acids. 2018;132:41-48. doi:10.1016/j.plefa.2018.03.004
  6. Mamounis KJ, Yasrebi A, Roepke TA. Linoleic acid causes greater weight gain than saturated fat without hypothalamic inflammation in the male mouse.J Nutr Biochem. 2017;40:122-131. doi:10.1016/j.jnutbio.2016.10.016
  7. Ravelli MN, Schoeller DA. Traditional Self-Reported Dietary Instruments Are Prone to Inaccuracies and New Approaches Are Needed.Front Nutr. 2020;7:90. Published 2020 Jul 3. doi:10.3389/fnut.2020.00090
  8. Berkowitz L, Araneda P, Cofré G, et al. The controversial role of linoleic acid in cardiometabolic health: from molecular pathways to human studies.Front Nutr. 2026;12:1728865. Published 2026 Jan 14. doi:10.3389/fnut.2025.1728865
  9. Trumbo P, Schlicker S, Yates AA, Poos M; Food and Nutrition Board of the Institute of Medicine, The National Academies. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids.J Am Diet Assoc. 2002;102(11):1621-1630. doi:10.1016/s0002-8223(02)90346-9

 

 

These statements have not been evaluated by the Food and Drug Administration. This test is not intended to diagnose, treat, cure, prevent or mitigate any disease. This site does not offer medical advice, and nothing contained herein is intended to establish a doctor/patient relationship. OmegaQuant, LLC is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) and is qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by OmegaQuant, LLC. It has not been cleared or approved by the U.S. Food and Drug Administration.